|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Immune system
|
 |
|
Title:
|
 |
Structure of interleukin-2 with its alpha receptor
|
|
Structure:
|
 |
Interleukin-2. Chain: a. Synonym: il-2, t-cell growth factor, tcgf, aldesleukin. Engineered: yes. Interleukin-2 receptor alpha chain. Chain: b. Fragment: extracellular domain. Synonym: il-2 receptor alpha subunit, p55, tac antigen, cd25 antigen.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: il2. Expressed in: trichoplusia ni. Expression_system_taxid: 7111. Gene: il2ra. Expression_system_taxid: 7111
|
|
Resolution:
|
 |
|
2.80Å
|
R-factor:
|
0.233
|
R-free:
|
0.280
|
|
|
Authors:
|
 |
M.Rickert,X.Q.Wang,N.Goriatcheva,M.J.Boulanger,K.C.Garcia
|
Key ref:
|
 |
M.Rickert
et al.
(2005).
The structure of interleukin-2 complexed with its alpha receptor.
Science,
308,
1477-1480.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
31-Mar-05
|
Release date:
|
07-Jun-05
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
extracellular region
|
2 terms
|
 |
|
Biological process
|
immune response
|
27 terms
|
 |
|
Biochemical function
|
protein binding
|
8 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Science
308:1477-1480
(2005)
|
|
PubMed id:
|
|
|
|
|
| |
|
The structure of interleukin-2 complexed with its alpha receptor.
|
|
M.Rickert,
X.Wang,
M.J.Boulanger,
N.Goriatcheva,
K.C.Garcia.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Interleukin-2 (IL-2) is an immunoregulatory cytokine that binds sequentially to
the alpha (IL-2Ralpha), beta (IL-2Rbeta), and common gamma chain (gammac)
receptor subunits. Here we present the 2.8 angstrom crystal structure of a
complex between human IL-2 and IL-2Ralpha, which interact in a docking mode
distinct from that of other cytokine receptor complexes. IL-2Ralpha is composed
of strand-swapped "sushi-like" domains, unlike the classical cytokine
receptor fold. As a result of this domain swap, IL-2Ralpha uses a composite
surface to dock into a groove on IL-2 that also serves as a binding site for
antagonist drugs. With this complex, we now have representative structures for
each class of hematopoietic cytokine receptor-docking modules.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Fig. 2. Domain swapping in IL-2R . (A) The IL-2R
model is
separated into D1 and D2 domains revealing the swapped A and B,
and F and G strand locations, respectively. Semitransparent
ovals in two diagrams of the separated sushi domains highlight
the corresponding strands, which are involved in the strand
swap. A surface representation of IL-2R in the center
shows the complete receptor molecule. (B) A representative
structure of a sushi domain, or CCP module [second domain of
ß[2] glycoprotein-1 (Protein Data Bank entry 1QUB [PDB]
)] (23, 32). The analogous strands to those involved in the
strand swap between IL-2R D1 and D2 domain
are blue and highlighted by a semitransparent oval.
|
 |
Figure 4.
Fig. 4. Comparison of receptor versus drug binding to IL-2. (A)
"Footprint" representation of IL-2 interface as viewed through
the IL-2R ß strands
onto the IL-2 surface. Contact residues of IL-2R (green and cyan
sticks) are projected onto the buried surface (orange) of IL-2.
The hydrophobic anchor residues Phe^42 and Tyr45 of IL-2 are
red. (B) Analogous footprint view of the drug compound 1 bound
to IL-2. Compound 1 is depicted with blue sticks [Protein Data
Bank entry name 1M48 [PDB]
(17)] projected onto the buried surface (orange) of IL-2.
Compound 1 uses IL-2 Phe^42 (red patch) as an anchor residue,
thereby preventing IL-2R from binding to
IL-2.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the AAAs:
Science
(2005,
308,
1477-1480)
copyright 2005.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.Guharoy,
A.Pal,
M.Dasgupta,
and
P.Chakrabarti
(2011).
PRICE (PRotein Interface Conservation and Energetics): a server for the analysis of protein-protein interfaces.
|
| |
J Struct Funct Genomics, 12,
33-41.
|
 |
|
|
|
|
 |
A.Láng,
K.Szilágyi,
B.Major,
P.Gál,
P.Závodszky,
and
A.Perczel
(2010).
Intermodule cooperativity in the structure and dynamics of consecutive complement control modules in human C1r: structural biology.
|
| |
FEBS J, 277,
3986-3998.
|
 |
|
|
|
|
 |
B.Li,
L.Zhao,
C.Wang,
H.Guo,
L.Wu,
X.Zhang,
W.Qian,
H.Wang,
and
Y.Guo
(2010).
The protein-protein interface evolution acts in a similar way to antibody affinity maturation.
|
| |
J Biol Chem, 285,
3865-3871.
|
 |
|
|
|
|
 |
D.J.Diller,
C.Humblet,
X.Zhang,
and
L.M.Westerhoff
(2010).
Computational alanine scanning with linear scaling semiempirical quantum mechanical methods.
|
| |
Proteins, 78,
2329-2337.
|
 |
|
|
|
|
 |
H.Yang,
J.Wang,
J.Du,
C.Zhong,
D.Zhang,
H.Guo,
Y.Guo,
and
J.Ding
(2010).
Structural basis of immunosuppression by the therapeutic antibody daclizumab.
|
| |
Cell Res, 20,
1361-1371.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Z.Tu,
M.Cohen,
H.Bu,
and
F.Lin
(2010).
Tissue distribution and functional analysis of Sushi domain-containing protein 4.
|
| |
Am J Pathol, 176,
2378-2384.
|
 |
|
|
|
|
 |
C.L.McClendon,
G.Friedland,
D.L.Mobley,
H.Amirkhani,
and
M.P.Jacobson
(2009).
Quantifying Correlations Between Allosteric Sites in Thermodynamic Ensembles.
|
| |
J Chem Theory Comput, 5,
2486-2502.
|
 |
|
|
|
|
 |
X.Wang,
P.Lupardus,
S.L.Laporte,
and
K.C.Garcia
(2009).
Structural biology of shared cytokine receptors.
|
| |
Annu Rev Immunol, 27,
29-60.
|
 |
|
|
|
|
 |
E.Mortier,
T.Woo,
R.Advincula,
S.Gozalo,
and
A.Ma
(2008).
IL-15Ralpha chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation.
|
| |
J Exp Med, 205,
1213-1225.
|
 |
|
|
|
|
 |
P.J.Lupardus,
and
K.C.Garcia
(2008).
The structure of interleukin-23 reveals the molecular basis of p40 subunit sharing with interleukin-12.
|
| |
J Mol Biol, 382,
931-941.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.Zeiser,
and
R.S.Negrin
(2008).
Interleukin-2 receptor downstream events in regulatory T cells: implications for the choice of immunosuppressive drug therapy.
|
| |
Cell Cycle, 7,
458-462.
|
 |
|
|
|
|
 |
S.L.LaPorte,
Z.S.Juo,
J.Vaclavikova,
L.A.Colf,
X.Qi,
N.M.Heller,
A.D.Keegan,
and
K.C.Garcia
(2008).
Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system.
|
| |
Cell, 132,
259-272.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
T.R.Malek
(2008).
The biology of interleukin-2.
|
| |
Annu Rev Immunol, 26,
453-479.
|
 |
|
|
|
|
 |
V.N.Uversky,
C.J.Oldfield,
and
A.K.Dunker
(2008).
Intrinsically disordered proteins in human diseases: introducing the D2 concept.
|
| |
Annu Rev Biophys, 37,
215-246.
|
 |
|
|
|
|
 |
D.M.Soper,
D.J.Kasprowicz,
and
S.F.Ziegler
(2007).
IL-2Rbeta links IL-2R signaling with Foxp3 expression.
|
| |
Eur J Immunol, 37,
1817-1826.
|
 |
|
|
|
|
 |
J.A.Wells,
and
C.L.McClendon
(2007).
Reaching for high-hanging fruit in drug discovery at protein-protein interfaces.
|
| |
Nature, 450,
1001-1009.
|
 |
|
|
|
|
 |
M.A.Williams,
and
M.J.Bevan
(2007).
Effector and memory CTL differentiation.
|
| |
Annu Rev Immunol, 25,
171-192.
|
 |
|
|
|
|
 |
M.Chirifu,
C.Hayashi,
T.Nakamura,
S.Toma,
T.Shuto,
H.Kai,
Y.Yamagata,
S.J.Davis,
and
S.Ikemizu
(2007).
Crystal structure of the IL-15-IL-15Ralpha complex, a cytokine-receptor unit presented in trans.
|
| |
Nat Immunol, 8,
1001-1007.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.Ma,
R.Koka,
and
P.Burkett
(2006).
Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis.
|
| |
Annu Rev Immunol, 24,
657-679.
|
 |
|
|
|
|
 |
A.Quéméner,
J.Bernard,
E.Mortier,
A.Plet,
Y.Jacques,
and
V.Tran
(2006).
Docking of human interleukin-15 to its specific receptor alpha chain: correlation between molecular modeling and mutagenesis experimental data.
|
| |
Proteins, 65,
623-636.
|
 |
|
|
|
|
 |
C.D.Thanos,
W.L.DeLano,
and
J.A.Wells
(2006).
Hot-spot mimicry of a cytokine receptor by a small molecule.
|
| |
Proc Natl Acad Sci U S A, 103,
15422-15427.
|
 |
|
|
|
|
 |
D.C.Fry
(2006).
Protein-protein interactions as targets for small molecule drug discovery.
|
| |
Biopolymers, 84,
535-552.
|
 |
|
|
|
|
 |
D.J.Stauber,
E.W.Debler,
P.A.Horton,
K.A.Smith,
and
I.A.Wilson
(2006).
Crystal structure of the IL-2 signaling complex: paradigm for a heterotrimeric cytokine receptor.
|
| |
Proc Natl Acad Sci U S A, 103,
2788-2793.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.L.Simmons
(2006).
What makes a good anti-inflammatory drug target?
|
| |
Drug Discov Today, 11,
210-219.
|
 |
|
|
|
|
 |
K.A.Smith
(2006).
The structure of IL2 bound to the three chains of the IL2 receptor and how signaling occurs.
|
| |
Med Immunol, 5,
3.
|
 |
|
|
|
|
 |
P.J.Kundrotas,
and
E.Alexov
(2006).
Electrostatic properties of protein-protein complexes.
|
| |
Biophys J, 91,
1724-1736.
|
 |
|
|
|
|
 |
M.D.Pescovitz
(2005).
Daclizumab: humanized monoclonal antibody to the interleukin-2 receptor.
|
| |
Expert Rev Clin Immunol, 1,
337-344.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|